Indianapolis, IN, United States of America

Yen Dao

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Yen Dao: Innovator in Pharmaceutical Chemistry

Introduction

Yen Dao is a notable inventor based in Indianapolis, IN (US), recognized for her contributions to pharmaceutical chemistry. With a total of three patents to her name, she has made significant strides in the development of innovative compounds that address critical health issues.

Latest Patents

Yen Dao's latest patents include groundbreaking work on bicyclic pyrimidine compounds, which serve as autotaxin inhibitors. This invention provides compounds of the Formula I, showcasing her expertise in creating effective therapeutic agents. Additionally, she has developed melanin concentrating hormone receptor antagonists, which are useful in treating obesity and related diseases. This patent relates to a compound of formula (1), wherein various components are defined, including pharmaceutically acceptable salts and enantiomers.

Career Highlights

Yen Dao is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her work focuses on developing innovative solutions that enhance patient care and improve health outcomes. Her dedication to research and development has positioned her as a key player in her field.

Collaborations

Yen collaborates with talented professionals, including her coworkers Kevin Matthew Gardinier and David Joseph Garmene. These partnerships foster a creative environment that drives innovation and accelerates the development of new therapies.

Conclusion

Yen Dao's contributions to pharmaceutical chemistry through her patents and collaborations highlight her commitment to advancing medical science. Her work continues to impact the field positively, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…